Ptc Therapeutics (PTCT) traded down -3.89 % during a 24 hours period ending at 11:03 PM Central Europe on Monday 26th. One Ptc Therapeutics stock can currently be bought for about USD 61.07 on popular exchanges. Current supply of Ptc Therapeutics stocks is 83.5 mn. Ptc Therapeutics has a current market capitalization of USD 5.1 bn and approximately USD 40.8 mn worth of Ptc Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Ptc Therapeutics has traded -2.71 % down. Simple moving average of last 200 days is at USD 71.04. The highest price of past 52 weeks was recorded at USD 90.87 on 07/09/2026. 52 weeks low was at USD 58.8 on 10/14/2026.
Here is how related stocks have performed in the past 24 hours:
Ligand (LGND) traded down -1.39 % and now trades at USD 308.3. Current market capitalisation for Ligand is USD 6.1 bn. Current price/earnings ratio for Ligand is 33.21.
Black Hills (BKH) traded up 0.13 % and now trades at USD 80.2. Current market capitalisation for Black Hills is USD 6.1 bn. Current price/earnings ratio for Black Hills is 19.91.
Home Bancshares (HOMB) traded down -0.17 % and now trades at USD 30.07. Home Bancshares has a market capitalisation of USD 6 bn. Home Bancshares has a current price to earnings ratio of 12.33.
Pjt (PJT) traded down -1.34 % and now trades at USD 142.9. Pjt has a market capitalisation of USD 6 bn. Current price/earnings ratio for Pjt is 22.83.
Klaviyo (KVYO) traded up 2.53 % and now trades at USD 20.71. Current market capitalisation for Klaviyo is USD 6 bn. Current price/earnings ratio for Klaviyo is 737.55.
About Ptc Therapeutics
PTC Therapeutics, Inc. is a biopharmaceutical company based in South Plainfield, United States. The company specializes in developing orally administered and small-molecule drugs for genetic disorders, oncology, and infectious diseases.
